No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
333 |
4. Check minimum number of eventsNone |
333 |
5. Include endpointsNone |
333 |
6. Filter based on genotype QC (FinnGen only) |
300 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of ureter, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of urinary organs, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 300 | 82 | 218 |
| Unadjusted period prevalence (%) | 0.08 | 0.03 | 0.10 |
| Median age at first event (years) | 73.40 | 73.44 | 73.38 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 315
- Matched controls
- 3150
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
307.7
292
*
UKC02
NOMESCO Finland
Cystoscopy
51.7
232.3
276
379
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
196.0
167
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
561.5
163.4
149
5
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
57.8
161.1
94
23
R31
ICD-10 Finland
Unspecified haematuria
18.3
159.0
196
260
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
69.2
153.9
86
17
UKB02
NOMESCO Finland
Retrograde ureteroscopy
271.2
144.4
138
9
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
60.3
110.7
63
13
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
308.7
108.1
104
5
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
1390.6
105.7
97
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
32.4
104.8
71
28
JN4AD
NOMESCO Finland
Body CT examination
14.4
104.5
114
119
H02AB02
ATC
dexamethasone; systemic
48.0
103.5
62
16
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
99.4
90
*
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
+∞
99.4
90
*
130
Kela drug reimbursment
Malignant tumour
+∞
95.8
87
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
41.6
93.4
58
17
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
90.0
82
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
85.4
78
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
17.6
83.9
75
55
KH1AD
NOMESCO Finland
CT of urinary organs
18.0
82.9
73
52
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
76.2
70
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
71.6
66
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
185.7
71.3
72
5
JN4BD
NOMESCO Finland
Extensive body CT
12.5
68.9
76
78
C61
ICD-10 Finland
Malignant neoplasm of prostate
811.9
68.7
65
*
Z51.5
ICD-10 Finland
Palliative care
11.3
64.6
77
88
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
62.6
58
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
370.6
61.7
60
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
150.6
59.2
61
5
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
125.6
58.2
61
6
A04AA01
ATC
ondansetron; systemic, rectal
20.5
57.9
46
26
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
8.9
57.4
84
124
B01AB10
ATC
tinzaparin; parenteral
7.9
53.9
89
150
JN4CD
NOMESCO Finland
Very extensive body CT
22.8
52.9
40
20
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
52.6
49
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.6
51.7
58
60
TPH07
NOMESCO Finland
Cathetrisation of artery
6.5
48.6
100
210
WX408
NOMESCO Finland
General anesthesy, balanced
5.4
48.0
142
413
A03FA01
ATC
metoclopramide; systemic, rectal
6.6
48.0
96
196
JN3AD
NOMESCO Finland
Abdominal CT examination
6.6
47.7
95
193
KBD00
NOMESCO Finland
Partial excision of ureter
+∞
47.1
44
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
68.8
46.0
52
9
KA1AE
NOMESCO Finland
Kidney ultrasound examination
15.5
45.9
42
31
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
42.7
40
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
42.7
40
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
12.0
41.1
44
42
KBH20
NOMESCO Finland
Replantation of ureter
413.7
37.9
37
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.9
37.8
113
323
J01MA02
ATC
ciprofloxacin; systemic
4.4
35.8
202
916
WX402
NOMESCO Finland
General anaesthesia
4.8
35.6
108
311
ZX136
NOMESCO Finland
Intravesicalis
202.4
35.5
36
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
35.1
33
*
U06
ICPC
Haematuria
10.3
33.7
40
44
TKC20
NOMESCO Finland
Catheterisation of bladder
6.0
33.7
69
141
WZC00
NOMESCO Finland
Treatment plan or consultation
4.2
33.4
138
497
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
32.9
31
*
8130/2-C66.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureter
+∞
32.9
31
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
358.3
32.5
32
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
31.8
30
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
31.8
30
*
KBB00
NOMESCO Finland
Biopsy of ureter
+∞
31.8
30
*
WZC30
NOMESCO Finland
Teaching
4.9
31.1
85
223
KA3EB
NOMESCO Finland
Antegrade pyelography
+∞
30.7
29
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.9
30.6
83
216
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
29.6
28
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.5
29.2
88
248
KC1GB
NOMESCO Finland
Cystography with X-ray
165.2
29.2
30
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.2
28.7
99
309
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
28.6
27
*
116
Kela drug reimbursment
Prostate cancer
+∞
27.5
26
*
N02AA05
ATC
oxycodone; systemic
4.0
27.5
101
329
B01AB05
ATC
enoxaparin; parenteral
3.6
27.2
150
639
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
57.1
26.7
31
6
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.1
25.7
33
40
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
24.3
23
*
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
+∞
24.3
23
*
J01EA01
ATC
trimethoprim; systemic
3.5
23.5
109
410
XKD00
NOMESCO Finland
Uroflowmetry
3.5
23.4
109
411
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
23.2
22
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.0
22.9
78
238
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.6
22.3
96
343
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
22.1
21
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
22.1
21
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
+∞
22.1
21
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
21.1
20
*
U76
ICPC
Malignant neoplasm of bladder
+∞
21.1
20
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
21.1
20
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
82.6
21.0
23
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
20.0
19
*
WX320
NOMESCO Finland
Spinalanesthesy
3.1
19.9
124
549
WF002
NOMESCO Finland
Radical radiotherapy
112.1
19.8
21
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
112.1
19.8
21
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
19.8
107
436
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.0
19.5
25
30
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
74.6
18.9
21
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
18.9
18
*
KBV10
NOMESCO Finland
Removal of stent from ureter
41.1
18.8
23
6
J01MA12
ATC
levofloxacin; systemic
3.2
18.4
95
375
N30.0
ICD-10 Finland
Acute cystitis
3.6
18.2
73
246
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
56.0
18.2
21
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
+∞
17.9
17
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
17.9
17
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
17.9
17
*
ZXE00
NOMESCO Finland
One hour or less
2.8
17.4
151
787
KBV00
NOMESCO Finland
Insertion of stent into ureter
53.1
17.2
20
*
KBD22
NOMESCO Finland
Retrograde ureteroscopic destruction of tumour of ureter
+∞
16.8
16
*
ZXC20
NOMESCO Finland
Use of chemical agents
16.5
16.5
26
17
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.4
16.3
28
47
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
15.8
15
*
A79
ICPC
Malignancy NOS
+∞
15.8
15
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
15.8
15
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
15.8
15
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
168.0
15.6
16
*
KA3GB
NOMESCO Finland
Retrograde pyelography
168.0
15.6
16
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
15.6
50
144
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
15.5
140
734
ZX120
NOMESCO Finland
Intravenous
4.5
15.5
41
102
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
17.2
15.5
24
15
Z3231
NOMESCO Finland
Registered nurse
2.8
15.5
111
519
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
21.4
15.3
22
11
ZX090
NOMESCO Finland
Other technic of radiotherapy
59.7
14.9
17
*
KCB00
NOMESCO Finland
Biopsy of bladder
84.1
14.7
16
*
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
14.7
195
1219
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
157.0
14.6
15
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.7
14.6
52
161
KCW96
NOMESCO Finland
Other operations on bladder
44.7
14.2
17
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
5.9
14.1
26
47
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.9
13.8
22
34
TJF80
NOMESCO Finland
Ostomy education
78.6
13.7
15
*
L02BB03
ATC
bicalutamide; oral
+∞
13.6
13
*
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
+∞
13.6
13
*
L03AA13
ATC
pegfilgrastim; parenteral
146.0
13.6
14
*
Y77
ICPC
Malignant neoplasm prostate
146.0
13.6
14
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
10.0
12.7
25
27
GD1AD
NOMESCO Finland
Thorax CT examination
4.1
12.7
37
99
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
12.6
12
*
A04AD12
ATC
aprepitant; systemic
+∞
12.6
12
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.6
12
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.6
12
*
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
+∞
12.6
12
*
L02BG04
ATC
letrozole; oral
+∞
12.6
12
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
12.6
12
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
12.6
12
*
L03AA02
ATC
filgrastim; parenteral
+∞
12.6
12
*
KH1DD
NOMESCO Finland
CT urography of urinary organs
135.2
12.5
13
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
135.2
12.5
13
*
R4110
NOMESCO Finland
Physiotherapy
2.5
11.8
103
519
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
11.5
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
124.4
11.5
12
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
17.9
11.3
17
10
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
4.0
10.6
31
83
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
113.7
10.5
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
113.7
10.5
11
*
UKD02
NOMESCO Finland
Urethroscopy
33.8
10.4
13
*
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
13.7
10.3
17
13
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
10.0
135
809
WX882
NOMESCO Finland
High dependency care
5.2
9.9
21
43
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.8
9.9
22
30
B02AA02
ATC
tranexamic acid; systemic
3.2
9.7
40
135
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.0
9.7
21
44
Z3226
NOMESCO Finland
Physiotherapist
2.5
9.6
69
315
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.0
9.6
46
170
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.0
9.6
21
28
N02AX02
ATC
tramadol; systemic, rectal
2.1
9.6
154
983
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.9
9.4
21
45
KBC00
NOMESCO Finland
Ureterectomy
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
KCD30
NOMESCO Finland
Destruction of tumour of bladder
+∞
9.4
9
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
9.4
9
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
+∞
9.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.4
9
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
9.4
9
*
Z2221
NOMESCO Finland
Medical doctor
2.3
9.4
90
467
U14
ICPC
Kidney symptom/complaint
8.1
9.3
20
26
R50.9
ICD-10 Finland
Fever, unspecified
2.6
9.2
59
254
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.4
9.1
23
55
N18.8
ICD-10 Finland
Other chronic renal failure
4.5
8.5
21
49
JFB00
NOMESCO Finland
Partial resection of small intestine
20.7
8.5
12
6
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.0
8.5
25
67
KC1GD
NOMESCO Finland
CT cystography of bladder
92.4
8.5
9
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
92.4
8.5
9
*
KED22
NOMESCO Finland
Transurethral resection of prostate
2.8
8.4
45
176
L01BC06
ATC
capecitabine; oral
+∞
8.4
8
*
WX224
NOMESCO Finland
Blockade of obturius nerve
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
8.4
8
*
U77
ICPC
Malignant neopl urinary tract other
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
C03CA01
ATC
furosemide; systemic
2.0
8.2
151
996
WX702
NOMESCO Finland
Supraglottic ventilation device
4.1
8.1
23
60
N20.1
ICD-10 Finland
Calculus of ureter
4.1
8.1
23
60
NK6AN
NOMESCO Finland
Total body bone isotope imaging
34.3
8.1
10
*
KA1FN
NOMESCO Finland
Isotope renography
22.7
8.1
11
5
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.9
8.1
24
65
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.2
7.9
32
107
JFB30
NOMESCO Finland
Right hemicolectomy
25.7
7.6
10
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
7.4
53
240
WX704
NOMESCO Finland
Intubation
3.1
7.4
31
106
SPAT1262
SPAT
Handing over of treatment supplies
2.2
7.3
75
396
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
UKC12
NOMESCO Finland
Retrograde endoscopy of cutaneous cystoenterostomy
+∞
7.3
7
*
Z93.6
ICD-10 Finland
Other artificial openings of urinary tract status
+∞
7.3
7
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
7.3
7
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
UKB12
NOMESCO Finland
Retrograde endoscopy of cutaneous ureteroenterostomy
+∞
7.3
7
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.1
7.3
20
51
WX110
NOMESCO Finland
Infiltration anesthesia
1.9
7.3
202
1509
S18
ICPC
Laceration/cut
1.9
7.2
164
1146
U70
ICPC
Pyelonephritis/pyelitis
8.2
7.2
15
19
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
30.8
7.2
9
*
U29
ICPC
Urinary symptom/complaint other
4.0
7.1
20
52
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.6
7.0
17
39
ZXA05
NOMESCO Finland
Left side
2.0
7.0
94
550
N02BE01
ATC
paracetamol; systemic, rectal
2.6
6.9
279
2367
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
11.3
6.9
12
11
A06AH03
ATC
naloxegol; oral
17.2
6.8
10
6
B03XA02
ATC
darbepoetin alfa; parenteral
7.4
6.8
15
21
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.3
6.8
58
284
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
6.7
64
327
KDE20
NOMESCO Finland
Removal of foreign body from urethra
23.1
6.7
9
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.1
6.7
14
18
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
12.6
6.6
11
9
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
9.0
6.6
13
15
R33
ICD-10 Finland
Retention of urine
2.3
6.6
52
246
WW500
NOMESCO Finland
Blood transfusion
5.9
6.5
17
30
HAB40
NOMESCO Finland
Wedge excision of mammary gland
71.2
6.4
7
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
6.4
46
209
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.8
6.3
19
52
KH1RT
NOMESCO Finland
Urinary tract dilatatation with radiological guidance
+∞
6.3
6
*
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
+∞
6.3
6
*
KBJ80
NOMESCO Finland
Operation for malfunction of urinary diversion
+∞
6.3
6
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.3
6
*
KBD20
NOMESCO Finland
Destruction of tumour of ureter
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
6.3
6
*
D30.2
ICD-10 Finland
Benign neoplasm: Ureter
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
6.3
6
*
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
+∞
6.3
6
*
7323
FHL
Electrosection of TU bladder wall change
+∞
6.3
6
*
8120/2-C66.9
ICD-O-3
Urothelial carcinoma in situ of ureter
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
6.5
6.2
15
24
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
12.9
6.1
10
8
J01DB01
ATC
cefalexin; oral
2.0
6.1
245
2006
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
10.3
6.1
11
11
G04BD12
ATC
mirabegron; oral
2.2
6.0
56
283
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
203
936
4.29
34.85
11.2
3.3
287.84
147.04
e6/l
0.50
178
716
165
661
4.14
34.58
6.8
2.4
4.38
4.30
e6/l
0.04
156
595
220
1115
4.23
32.01
4.4
2.5
—
—
estimate
—
0
0
179
802
3.85
30.98
11.0
3.1
0.38
0.36
e6/l
0.04
162
584
203
1017
3.80
29.04
12.4
3.9
247.41
109.70
e6/l
0.57
180
733
64
147
5.21
27.19
4.4
1.3
52.69
2.81
ug/l
0.99
56
113
268
1686
4.95
26.03
15.6
4.9
4.80
2617.24
e6/l
—
5
34
226
1287
3.68
24.97
10.5
3.9
9.41
12.81
umol/l
12.43
220
1216
138
583
3.43
24.95
3.6
2.2
—
—
—
0
0
86
276
3.91
23.53
9.3
7.0
12.08
11.34
mmol/l
0.34
79
261
222
1332
3.26
20.81
13.8
5.4
4.65
4.49
e9/l
0.40
191
1134
205
1199
3.03
19.66
7.8
4.0
32.63
35.04
g/l
6.94
197
1118
227
1429
3.11
18.59
23.8
18.4
1.28
1.37
inr
1.79
204
1209
110
475
3.02
18.19
11.1
3.1
1.13
1.27
e6/l
0.15
82
233
224
1419
3.00
17.76
10.9
6.2
1.20
1.21
mmol/l
0.56
192
1210
77
285
3.25
16.43
4.2
2.3
232.19
239.57
u/l
0.33
72
268
112
515
2.82
16.22
10.6
2.9
1.61
1.03
e6/l
1.08
81
275
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
42
105
4.46
15.80
3.7
2.4
0.43
0.40
iu/ml
0.10
18
56
234
1619
2.73
13.89
8.4
5.0
7.00
6.89
mmol/l
0.43
228
1544
199
1276
2.52
13.86
10.2
5.9
1.20
1.20
mmol/l
0.45
183
1150
87
395
2.66
12.50
7.5
6.8
5.19
5.08
kpa
0.59
82
386
87
395
2.66
12.50
7.4
6.8
13.47
11.27
kpa
3.68
81
386
203
1352
2.41
12.42
7.0
4.1
0.00
0.00
estimate
-0.00
54
279
257
1913
2.87
12.33
13.4
5.5
86.73
79.45
u/l
1.99
251
1769
86
392
2.64
12.24
7.4
6.8
-0.88
1.16
mmol/l
3.47
67
324
203
1374
2.34
11.65
7.2
4.1
23.79
0.00
estimate
0.49
56
288
203
1384
2.31
11.30
7.2
4.1
0.00
0.01
estimate
0.50
54
267
138
828
2.19
10.23
4.4
2.2
54.17
65.04
u/l
1.06
132
759
87
433
2.39
10.07
3.6
2.8
19.45
22.64
%
1.35
80
400
61
263
2.64
9.53
5.4
2.4
0.29
0.43
e6/l
0.77
61
248
89
466
2.27
9.06
3.4
2.7
2.12
2.19
g/l
0.49
82
429
96
520
2.22
8.99
2.1
1.9
—
—
—
0
0
94
509
2.21
8.78
3.4
2.7
10.35
12.42
umol/l
2.15
88
472
90
485
2.20
8.47
2.5
1.9
29.44
29.93
s
0.42
90
468
128
792
2.04
8.36
2.4
2.3
2.81
2.85
mg/l
0.07
112
671
138
898
1.96
7.65
5.4
2.1
2.33
2.35
mmol/l
0.58
128
776
45
188
2.63
7.43
6.3
4.0
0.63
2.43
mmol/l
1.93
33
138
38
160
2.56
6.16
1.8
1.5
—
—
—
0
0
157
1119
1.80
6.16
3.7
3.1
183.10
145.01
ug/l
1.09
143
1021
65
352
2.07
5.86
6.9
3.5
0.24
1.83
mmol/l
2.42
56
305
118
786
1.80
5.70
7.3
4.1
0.00
0.00
estimate
-0.00
46
253
276
2392
2.24
5.43
37.0
16.4
42.06
27.78
mg/l
7.17
266
1956
108
715
1.78
5.25
2.5
2.6
370.66
370.42
umol/l
0.01
90
605
106
698
1.78
5.24
6.7
3.7
0.09
0.00
estimate
0.49
33
217
69
399
1.93
5.14
1.9
1.8
—
—
—
0
0
93
594
1.80
5.07
4.0
2.1
2.50
2.44
mmol/l
3.72
82
515
95
615
1.78
4.94
5.0
4.5
64.42
401.10
ng/l
3.08
84
536
179
1382
1.68
4.86
2.6
2.3
86.88
94.00
pmol/l
1.41
112
728
56
308
2.00
4.80
6.3
3.5
—
—
—
0
0
63
374
1.86
4.30
1.8
1.9
—
—
—
0
0
12
26
4.75
4.10
3.4
2.1
-0.26
1.60
mmol/l
0.85
12
26
46
251
1.98
4.03
5.4
1.8
407.80
379.69
nmol/l
0.28
46
229
39
201
2.07
3.99
1.6
1.6
—
—
—
0
0
149
1136
1.59
3.97
2.4
2.5
80.32
78.88
nmol/l
0.22
132
979
25
107
2.45
3.94
2.5
1.5
—
—
—
0
0
178
1422
1.58
3.84
3.5
3.1
71.38
53.12
u/l
0.94
170
1300
40
214
2.00
3.70
8.0
3.2
1.21
1.22
mmol/l
0.23
35
173
262
2321
1.77
3.53
42.4
16.4
57.52
71.77
ml/min/173m2
20.62
256
2148
223
1899
1.60
3.48
4.2
4.4
18.60
13.35
mm/h
3.28
205
1735
42
234
1.92
3.47
6.8
4.1
160.55
103.81
ng/l
1.12
37
199
13
43
3.11
3.29
4.2
3.6
9.72
12.60
pmol/l
0.49
13
43
133
1031
1.50
3.07
7.6
4.3
0.03
0.01
estimate
0.19
37
225
34
186
1.93
2.97
1.9
1.6
—
—
—
0
0
24
115
2.18
2.97
2.9
1.6
—
—
—
0
0
15
58
2.67
2.92
1.5
2.6
88.40
84.26
%
0.32
15
58
76
1040
0.65
2.80
2.0
2.0
1.70
1.26
mmol/l
1.06
65
835
137
1097
1.44
2.57
2.5
2.2
—
—
—
0
0
5
7
7.23
2.56
2.0
1.0
879.00
104.29
nmol/l
—
5
7
6
11
5.54
2.55
10.2
2.9
0.33
0.91
index
—
6
11
17
76
2.31
2.49
8.8
3.1
1.60
1.35
index
—
10
37
279
2581
1.71
2.40
55.6
25.0
4.17
4.45
e12/l
13.94
274
2490
279
2581
1.71
2.40
55.7
25.0
238.29
233.60
e9/l
0.50
274
2505
16
72
2.29
2.31
1.4
1.5
—
—
—
0
0
6
13
4.68
2.28
2.2
1.1
—
—
—
0
0
136
1109
1.40
2.22
2.7
3.4
2845.39
1841.91
ng/l
0.68
124
964
5
9
5.62
2.22
2.2
1.1
134.40
5.18
nmol/l
—
5
9
272
2518
1.59
2.11
18.4
10.8
25.11
25.23
u/l
0.04
266
2401
134
1110
1.36
1.92
4.4
4.3
15.20
8.48
mg/mmol
0.63
90
711
24
137
1.81
1.89
2.7
2.5
293.17
704.74
ug/l
0.66
24
130
7
22
3.23
1.89
1.3
1.2
—
—
—
0
0
7
23
3.09
1.81
1.3
1.2
—
—
—
0
0
7
23
3.09
1.81
1.3
1.2
—
—
—
0
0
7
24
2.96
1.73
1.3
1.2
—
—
—
0
0
7
24
2.96
1.73
1.3
1.2
—
—
—
0
0
7
24
2.96
1.73
1.3
1.2
—
—
—
0
0
20
111
1.86
1.73
2.5
1.4
11.08
11.06
g/l
0.01
20
97
244
2241
1.39
1.68
5.7
5.0
2.09
2.04
mu/l
0.13
224
1991
22
129
1.76
1.61
2.4
1.4
7.79
7.40
g/l
0.61
22
115
22
129
1.76
1.61
2.4
1.4
4.05
3.78
g/l
0.57
22
115
30
192
1.62
1.61
4.2
2.8
0.66
0.62
%
0.22
30
192
8
32
2.54
1.61
1.3
1.6
—
—
—
0
0
8
32
2.54
1.61
1.0
1.4
—
—
—
0
0
7
26
2.73
1.59
1.3
1.2
—
—
—
0
0
130
1098
1.31
1.56
3.5
3.5
6.51
7.60
mmol/l
2.78
104
916
20
116
1.77
1.52
3.5
3.6
—
—
—
0
0
25
155
1.67
1.52
2.5
1.8
1.60
1.58
g/l
0.05
18
135
30
197
1.58
1.47
4.1
2.8
1.52
1.06
%
0.60
30
197
32
217
1.53
1.37
6.2
2.3
49.50
57.87
ml/min/173m2
0.92
18
84
78
623
1.33
1.37
1.8
1.9
1012.75
1194.74
nmol/l
1.09
55
475
17
100
1.74
1.26
2.8
1.4
0.00
0.01
g/l
0.49
17
90
163
1448
1.26
1.24
5.3
4.6
2.34
2.13
ug/l
0.22
139
1286
116
994
1.26
1.19
1.9
1.8
18.90
20.19
nmol/l
0.41
101
833
6
26
2.33
1.19
5.2
2.5
—
—
—
0
0
15
87
1.76
1.17
3.0
1.4
0.00
0.00
g/l
-0.00
15
82
18
111
1.66
1.15
3.9
1.4
1.67
0.42
g/l
0.69
18
97
31
220
1.45
1.10
1.4
1.5
—
—
—
0
0
23
153
1.54
1.10
7.9
3.6
1.02
1.02
ratio
0.24
23
142
12
68
1.79
1.02
1.2
1.3
—
—
—
0
0
197
1812
1.23
1.01
4.2
3.8
15.15
15.10
pmol/l
0.08
176
1600
31
417
0.72
0.98
1.2
1.3
31.28
38.69
iu/ml
—
5
123
12
69
1.77
0.98
1.2
1.3
—
—
—
0
0
15
94
1.63
0.92
5.9
1.3
3.32
1.49
ratio
—
9
54
29
389
0.72
0.91
1.2
1.3
3.14
10.74
u/ml
—
8
121
10
56
1.81
0.89
1.4
1.3
—
—
—
0
0
10
56
1.81
0.89
1.4
1.3
—
—
—
0
0
11
64
1.74
0.87
1.3
1.2
—
—
—
0
0
134
1202
1.20
0.84
4.9
4.4
48.92
75.94
ng/l
0.46
118
960
0
24
0.00
0.79
0.0
1.1
—
1.34
—
0
15
5
25
2.02
0.73
1.2
1.4
—
—
—
0
0
5
26
1.94
0.71
1.2
1.2
8.60
11.14
u/l
—
5
21
7
41
1.72
0.70
1.0
1.4
—
—
—
0
0
7
44
1.60
0.65
2.0
2.5
9.29
11.09
mmol/l
—
7
44
80
703
1.18
0.62
1.9
1.9
364.39
26352949.16
pmol/l
0.78
62
573
0
21
0.00
0.60
0.0
1.6
—
72.30
—
0
21
0
21
0.00
0.60
0.0
1.1
—
3.06
—
0
8
11
72
1.55
0.60
1.4
1.6
—
—
—
0
0
5
87
0.57
0.57
1.0
1.4
1.00
1.07
g/l
—
5
82
6
36
1.68
0.57
1.5
1.4
32197.17
71548.05
e6/l
—
6
19
6
38
1.59
0.54
1.2
1.0
—
—
—
0
0
10
66
1.53
0.53
4.3
4.2
21.90
27.39
mg/l
—
5
55
10
67
1.51
0.50
1.1
1.4
—
—
—
0
0
7
45
1.57
0.49
2.9
2.4
1.20
1.19
mmol/l
—
7
45
7
47
1.50
0.48
2.9
2.4
108.57
105.43
mmol/l
—
7
47
74
662
1.15
0.47
8.4
4.4
1.02
1.02
kg/l
0.06
63
449
12
86
1.41
0.45
1.1
1.3
—
—
—
0
0
5
31
1.62
0.43
1.0
1.1
—
15.43
—
0
7
8
57
1.41
0.42
1.1
1.2
—
—
—
0
0
5
32
1.57
0.42
1.0
1.3
—
—
—
0
0
5
32
1.57
0.42
2.8
3.9
—
—
—
0
0
5
32
1.57
0.42
2.0
2.3
—
354.40
—
0
5
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
0
17
0.00
0.41
0.0
2.4
—
—
—
0
0
5
34
1.48
0.40
1.2
1.2
—
—
—
0
0
9
67
1.35
0.38
1.2
1.2
—
—
—
0
0
5
77
0.64
0.36
1.0
1.3
—
—
—
0
0
31
360
0.85
0.35
9.6
7.6
—
—
—
0
0
11
83
1.34
0.32
4.9
3.6
0.74
0.83
nmol/l
0.32
11
67
88
818
1.11
0.31
2.5
3.1
0.65
0.77
ug/l
0.91
63
576
247
2413
1.11
0.29
6.3
5.9
6.21
6.18
mmol/l
0.16
221
2159
58
529
1.12
0.29
1.5
1.7
2.50
1.52
mg/l
0.76
47
414
231
2259
1.08
0.23
4.5
4.8
1.29
1.25
mmol/l
0.48
203
2023
7
92
0.76
0.23
1.0
1.0
—
—
—
0
0
5
41
1.22
0.22
1.4
1.1
—
—
—
0
0
8
101
0.79
0.21
1.3
1.9
30.10
37.58
u/l
—
8
86
0
11
0.00
0.21
0.0
1.1
—
36.11
—
0
11
26
230
1.14
0.21
1.2
1.3
—
—
—
0
0
5
43
1.17
0.21
1.4
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
6
51
1.18
0.19
2.7
1.4
—
—
—
0
0
7
58
1.21
0.18
1.3
1.2
—
—
—
0
0
5
66
0.75
0.17
1.0
1.2
—
—
—
0
0
241
2374
1.06
0.15
8.6
7.7
41.37
40.77
mmol/mol
0.54
220
2189
12
102
1.18
0.15
3.0
2.7
3.64
4.29
pmol/l
1.33
12
90
51
483
1.07
0.13
1.2
1.3
0.89
1.67
u/ml
0.89
12
136
15
135
1.12
0.10
1.2
1.4
—
—
—
0
0
5
47
1.06
0.09
1.2
1.3
—
—
—
0
0
246
2436
1.04
0.09
6.1
6.8
2.31
2.43
mmol/l
1.50
225
2216
14
155
0.90
0.09
2.4
2.6
—
12.27
—
0
7
12
134
0.89
0.09
1.3
1.4
—
35.25
—
0
12
36
342
1.06
0.08
5.0
5.6
33.43
33.10
%
0.06
23
208
5
62
0.80
0.08
1.8
1.5
—
—
—
0
0
5
64
0.78
0.08
1.0
1.6
—
—
—
0
0
7
67
1.05
0.08
1.3
1.2
—
—
—
0
0
8
76
1.05
0.07
1.0
1.2
—
4.21
—
0
9
121
1191
1.03
0.05
3.8
4.3
20.20
24.56
%
3.06
66
618
237
2384
0.98
0.04
5.3
5.8
4.10
4.28
mmol/l
1.96
214
2179
19
198
0.96
0.02
6.2
3.9
57.53
47.39
%
1.37
19
192
236
2366
0.99
0.00
5.2
5.7
1.33
1.41
mmol/l
2.31
216
2137
14
136
1.03
0.00
1.1
1.2
235.19
351.15
u/ml
0.27
14
125
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
9.53
—
0
9
0
9
0.00
0.00
0.0
1.0
—
2176.11
—
0
9
6
66
0.91
-0.00
1.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
8
82
0.97
-0.00
1.1
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
53
0.94
-0.00
1.8
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
0.48
—
0
7
0
7
0.00
-0.00
0.0
1.4
—
9.86
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_URETER_WIDE – Malignant neoplasm of ureter, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).